
Ashok Kumar
About Ashok Kumar
Data last updated:
Ashok Kumar is a Director at Regenmedica Private Limited (since 2022) and Director at Hemovera Solutions Private Limited (since 2026). The companies operate in Manufacturing. The largest current company by reported revenue is Regenmedica Private Limited at ₹29.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Apr 2022 | 2022 | ₹29.1 Lakh (FY 2024) | Active | |
| Director | 07 Jul 2026 | 2026 | Active |
Board colleagues of Ashok Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aklesh Kumar Jain | 09577493 | Regenmedica Private Limited | Director |
| Amar Nath Koul | 09577472 | Regenmedica Private Limited | Director |
| Irfan Qayoom | 09544162 | Regenmedica Private Limited | Director |
| Ashiq Hussain Pandit | 11807887 | Hemovera Solutions Private Limited | Director |
| Samer Jeet Singh | 07916188 | Hemovera Solutions Private Limited | Individual Subscriber |
| Shreya Mehrotra | 11706733 | Hemovera Solutions Private Limited | Individual Subscriber |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Kumar
Ashok Kumar currently holds 2 directorships: Regenmedica Private Limited (Director, since 19 Apr 2022, revenue ₹29.1 Lakh (FY 2024)); Hemovera Solutions Private Limited (Director, since 07 Jul 2026).
Ashok Kumar was first appointed on 19 Apr 2022 as Director at Regenmedica Private Limited. The most recent appointment on record is 07 Jul 2026 at Hemovera Solutions Private Limited.
The current boards of Ashok Kumar's companies include Aklesh Kumar Jain (Regenmedica Private Limited), Amar Nath Koul (Regenmedica Private Limited), Irfan Qayoom (Regenmedica Private Limited), Ashiq Hussain Pandit (Hemovera Solutions Private Limited), Samer Jeet Singh (Hemovera Solutions Private Limited), Shreya Mehrotra (Hemovera Solutions Private Limited).